Table 5.
Groups | TC (mg/dL) | TG (mg/dL) | HDL-C (mg/dL) | LDL-C (mg/dL) |
---|---|---|---|---|
NOR | 63.1 ± 9.3 a | 62.6 ± 10.3 ab | 28.3 ± 1.9 bc | 24.2 ± 6.2 ab |
HF | 65.1 ± 8.6 a | 94.5 ± 17.5 c | 22.6 ± 2.4 a | 31.5 ± 7.9 b |
UPW-R-1X | 63.5 ± 6.9 a | 69.8 ± 8.4 b | 27.3 ± 3.6 bc | 27.2 ± 7.3 ab |
DOW-R-1X | 64.6 ± 7.9 a | 52.8 ± 8.5 a | 28.8 ± 1.6 c | 25.2 ± 6.6 ab |
DOW-R-2X | 62.9 ± 2.3 a | 60.5 ± 20.1 ab | 26.3 ± 2.0 bc | 22.0 ± 6.6 a |
MS | 67.0 ± 16.1 a | 67.1 ± 14.5 ab | 22.5 ± 3.5 a | 24.5 ± 13.2 ab |
AK | 60.2 ± 6.8 a | 60.4 ± 4.6 ab | 22.2 ± 1.1 a | 18.6 ± 5.4 a |
NOR, normal diet (3.34 kcal/g); HF, high-fat diet (4.17 kcal/g); UPW-R-1X, UPW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-1X, DOW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-2X, DOW-RMD powder (2×, 55.62 mg/day 100 g bw) and high-fat diet; and high-fat diet; MS, monascin powder (2×, 0.152 mg/day 100 g bw) and high-fat diet; AK, ankaflavin powder (2×, 0.162 mg/day 100 g bw) and high-fat diet. Data are presented as means ± SD (n = 8). Mean values within each column with different superscripts are significant difference (p < 0.05).